NFE2L2 and cancer: Since oxidative stress is considered an important metabolic stress that could limit as well as enhance the survival of cancer cells and impact the host’s response to cancer [57,58,59], NRF2 inhibition is considered an attractive treatment option to counteract the survival and proliferative advantage of cancer cells and reverse resistance to anti-cancer therapies [60].